대한간호학회지 (Journal of Korean Academy of Nursing)

한국간호과학회 (Korean Society of Nursing Science)
권호 표지
DOI QR코드

DOI QR Code

유방암 환자에서 화학요법이 인지기능에 미치는 영향에 대한 메타분석

A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer

  • 투고 : 2012.04.13
  • 심사 : 2012.09.21
  • 발행 : 2012.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The purpose of this study was to evaluate the cognitive effects of chemotherapy in patients with breast cancer. Methods: Using several databases, prospective studies were collected up to August 2011. Of 2,106 publications identified, 12 met the inclusion criteria, and 8 studies were used to estimate the effect size of chemotherapy on cognitive impairment. Results: Twelve studies were done since 2005 and most of the research was performed in Europe or North America. Eight studies were used to generate effect size across the cognitive domains of attention/concentration, verbal and visual memory, executive function, visuospatial skill, language, and subjective cognitive function. Each of the cognitive domains showed small effect sizes (-0.02 ~ -0.26), indicating diminished cognitive function for the chemotherapy group compared with non-chemotherapy groups. Conclusion: Finding suggests that breast cancer patients who undergo chemotherapy may experience mild cognitive decline. Further study is needed to generate knowledge and guideline for interventions to address chemotherapy related cognitive impairment in these patients.

키워드

참고문헌

  1. Ahles, T. A., & Saykin, A. J. (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3(Suppl 3), S84-S90. http://dx.doi.org/10.3816/CBC.2002.s.018
  2. Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440. http://dx.doi.org/10.1200/JCO.2009.27.0827
  3. Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430. http://dx.doi.org/10.1002/pon.964
  4. Braver, T. S., & Barch, D. M. (2002). A theory of cognitive control, aging cognition, and neuromodulation. Neuroscience and Biobehavioral Reviews, 26, 809-817. http://dx.doi.org/10.1016/S0149-7634(02)00067-2
  5. Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology, 18, 134-143. http://dx.doi.org/10.1002/pon.1379
  6. Cusimano, A. (2001). Learning disabilities: There is a cure. Pennsylvania, PA: Achieve Publications.
  7. Debess, J., Riis, J. O., Engebjerg, M. C., & Ewertz, M. (2010). Cognitive function after adjuvant treatment for early breast cancer: A population-based longitudinal study. Breast Cancer Research and Treatment, 121, 91-100. http://dx.doi.org/10.1007/s10549-010-0756-8
  8. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188. http://dx.doi.org/10.1016/0197-2456(86)90046-2
  9. Egger, M., Davey Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634. http://dx.doi.org/10.1136/bmj.315.7109.629
  10. Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70. http://dx.doi.org/10.1016/j.bandc.2005.05.001
  11. Fan, H. G., Houede-Tchen, N., Yi, Q. L., Chemerynsky, I., Downie, F. P., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology, 23, 8025-8032. http://dx.doi.org/10.1200/JCO.2005.01.6550
  12. Gazzaniga, M. S., Ivry, R. B., & Mangun, G. R. (2002). Cognitive neuroscience: The biology of the mind (2nd ed.). New York, NY: W.W. Norton & Company.
  13. Glogoski, C., Milligan, N. V., & Wheatley, C. J. (2006). Evaluation and treatment of cognitive dysfunction. In H. M. Pendleton & W. Schultz-Krohn (Eds.), Pedretti's occupational therapy: Practice skills for physical dysfunction (6th ed.)(pp. 589-608). St. Louis, MO: Mosby Elsevier.
  14. Isaki, E., Spaulding, T. J., & Plante, E. (2008). Contributions of language and memory demands to verbal memory performance in language-learning disabilities. Journal of Communication Disorders, 41, 512-530. http://dx.doi.org/10.1016/j.jcomdis.2008.03.006
  15. Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2007). A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum, 34, 997-1005. http://dx.doi.org/10.1188/07.ONF.997-1005
  16. Kim, G. D., Chung, B. Y., Kim, K. H., Byun, H. S., & Choi, E. H. (2011). Analysis of a trend of instrument usage to assess cognitive function of breast cancer patients undergoing chemotherapy. Journal of Korean Oncology Nursing, 11, 179-185. http://dx.doi.org/10.5388/jkon.2011.11.3.179
  17. Knobf, M. T. (2011). Clinical update: Psychosocial responses in breast cancer survivors. Seminars in Oncology Nursing, 27, e1-e14. http://dx.doi.org/10.1016/j.soncn.2011.05.001
  18. Korean National Statistical Office. (2009). Annual report on cause of death statistics. Seoul: Author.
  19. Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York, NY: Oxford University Press.
  20. Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. (2005). Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer, 12, 279-287. http://dx.doi.org/10.2325/jbcs.12.279
  21. Myers, J. S. (2009). Chemotherapy-related cognitive impairment. Clinical Journal of Oncology Nursing, 13, 413-421. http://dx.doi.org/10.1188/09.CJON.413-421
  22. National Evidence-based Healthcare Collaborating Agency. (2011). NECA's guidance for systematic review for new health technology assessment. Seoul: Author.
  23. Nelson, C. J., Nandy, N., & Roth, A. J. (2007). Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliative and Supportive Care, 5, 273-280. http://dx.doi.org/10.1017/S1478951507000442
  24. Noal, S., Levy, C., Hardouin, A., Rieux, C., Heutte, N., Segura, C., et al. (2011). One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 81, 795-803. http://dx.doi.org/10.1016/j.ijrobp.2010.06.037
  25. Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009). Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology, 31, 73-89. http://dx.doi.org/10.1080/13803390801992725
  26. Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research and Treatment, 116, 113-123. http://dx.doi.org/10.1007/s10549-008-0114-2
  27. Rosenthal, R. (1991). Meta-analytic procedures for social research. Newbury Park, CA: Sage Publications.
  28. Scottish Intercollegiate Guidelines Network. (2011). SIGN 50: A guideline developer's handbook. Retrieved January, 11, 2012, from http://www.sign.ac.uk/pdf/sign50.pdf
  29. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20, 76-89. http://dx.doi.org/10.1080/138540491005875
  30. Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M., Cheung, Y. K., Fang, Y., et al. (2010). The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast cancer Research and Treatment, 123, 25-34. http://dx.doi.org/10.1007/s10549-009-0606-8

피인용 문헌

  1. 유방암 환자에서 화학요법관련 인지기능저하의 발생률과 발생양상 vol.45, pp.1, 2015, https://doi.org/10.4040/jkan.2015.45.1.118
  2. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30 vol.25, pp.3, 2016, https://doi.org/10.1007/s11136-015-1217-y
  3. 대장암 환자의 항암화학요법 관련 인지손상과 삶의 질: 심리적 디스트레스(우울·불안)의 매개효과 vol.46, pp.1, 2012, https://doi.org/10.4040/jkan.2016.46.1.19
  4. The Impact of Cancer on Psychological and Social Outcomes vol.51, pp.2, 2012, https://doi.org/10.1111/ap.12165
  5. 항암화학요법을 받은 유방암 여성의 인지기능과 암 대처가 삶의 질에 미치는 영향 vol.22, pp.3, 2012, https://doi.org/10.4069/kjwhn.2016.22.3.182
  6. Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study vol.25, pp.6, 2012, https://doi.org/10.1007/s00520-017-3589-8